Sprycel Market, By Application (Chronic myeloid leukemia (CML), Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia), By Age Group (Adult Patients, Pediatric Patients), By Distribution Channel: (etail Pharmacies, Online Pharmacies and Specialty

Sprycel Market, By Application (Chronic myeloid leukemia (CML), Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia), By Age Group (Adult Patients, Pediatric Patients), By Distribution Channel: (etail Pharmacies, Online Pharmacies and Specialty Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Sprycel is the brand name for dasatinib, a medication used in the treatment of certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). Dasatinib works by inhibiting the activity of specific tyrosine kinases, which are enzymes involved in the growth and spread of cancer cells. Sprycel is a targeted medication primarily employed in the treatment of certain types of leukemia, specifically acute lymphoblastic leukemia (ALL), characterized by the presence of the Philadelphia chromosome (Ph+ ALL), and chronic myeloid leukemia (CML). Common side effects of Sprycel may include fatigue, headache, nausea, diarrhea, and fluid retention. Some patients may also experience more serious side effects, such as low blood cell counts, liver problems, and bleeding. Close monitoring by healthcare providers is important to manage and address any adverse effects. It is administered to both adults and children aged 12 months and older who are diagnosed with CML. Additionally, it is prescribed for adults and children in the same age group who are afflicted with a specific subtype of acute lymphoblastic leukemia known as Philadelphia chromosome-positive or Ph+ ALL. Leukemia is a malignancy involving immature white blood cells that develop within the bone marrow. In the normal course of events, as these white blood cells mature, they enter the bloodstream to combat infections and maintain the body's immune system.

Market Dynamics:

The increasing prevalence of targeted indications, their efficacy and safety profile, expanded indications, and innovative advancements are major factors expected to drive growth of the global sprycel market during the forecast period. Advancements in cancer research and treatment, including the development of targeted therapies like Sprycel, have expanded the options available to healthcare providers and patients. This has led to increased adoption of Sprycel as part of the treatment regimen.

However, strong competition, patent expiration, regulatory challenges, adverse effects, and pricing and reimbursement are expected to hamper the growth of the global Sprycel market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global Sprycel market, and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Sprycel market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bristol-Myers Squibb (BMS)
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Sprycel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sprycel market
Detailed Segmentation:
  • By Application:
  • Chronic myeloid leukemia (CML)
  • Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
  • By Age Group:
  • Adult Patients
  • Pediatric Patients
  • By Distribution Channel:
  • Hospitals and Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • By Company Profiles:
  • Bristol-Myers Squibb (BMS)


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Global Sprycel, By Application
Market Global Sprycel, By Age Group
Market Global Sprycel, By Distribution Channel
Market Global Sprycel, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of targeted indications, efficacy and safety profile, expanded indications
Strong competition, patent expiration, regulatory challenges
Innovative advancements
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Sprycel Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Sprycel Market, By Application, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Chronic myeloid leukemia (CML)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Global Sprycel Market, By Age Group, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Adult Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pediatric Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Global Sprycel Market, By Distribution Channel, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Specialty Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
8. Global Sprycel Market, By Region, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Bristol-Myers Squibb (BMS)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Sprycel Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings